Jefferies Initiates Coverage On Syndax Pharmaceuticals with Buy Rating, Announces Price Target of $37
Syndax Pharmaceuticals Inc +2.45% Pre
Syndax Pharmaceuticals Inc SNDX | 19.21 19.21 | +2.45% 0.00% Pre |
Jefferies analyst Kelly Shi initiates coverage on Syndax Pharmaceuticals (NASDAQ:
SNDX) with a Buy rating and announces Price Target of $37.